Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1995 Jul;33(7):1842–1846. doi: 10.1128/jcm.33.7.1842-1846.1995

Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method.

R Gomez-Flores 1, S Gupta 1, R Tamez-Guerra 1, R T Mehta 1
PMCID: PMC228282  PMID: 7665657

Abstract

We investigated the potential of a rapid colorimetric microassay based on the reduction of dimethylthiazol-diphenyltetrazolium bromide (MTT) for determining the growth of Mycobacterium avium-M. intracellulare complex (MAC) and MICs of clofazimine, resorcinomycin A, and the quinolone PD 127391 against MAC. The reduction of MTT was directly proportional to the number of viable bacteria. A comparison of the MTT reduction test with the [3H]glycerol uptake assay showed the former to possess higher analytical sensitivity for detecting MAC growth in microtiter plates. The MIT reduction test avoids the use of radioisotopes and costly material and equipment; it is reliable, reproducible, and convenient for rapid routine susceptibility testing of MAC.

Full Text

The Full Text of this article is available as a PDF (206.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agins B. D., Berman D. S., Spicehandler D., el-Sadr W., Simberkoff M. S., Rahal J. J. Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis. 1989 Apr;159(4):784–787. doi: 10.1093/infdis/159.4.784. [DOI] [PubMed] [Google Scholar]
  2. Blanchard D. K., Michelini-Norris M. B., Djeu J. Y. A rapid [3H]glycerol radioassay for determination of monocyte-mediated growth inhibition of Mycobacterium avium. J Immunol Methods. 1990 Oct 19;133(2):285–290. doi: 10.1016/0022-1759(90)90370-b. [DOI] [PubMed] [Google Scholar]
  3. Cynamon M. H. Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare. Antimicrob Agents Chemother. 1985 Sep;28(3):440–441. doi: 10.1128/aac.28.3.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Garrelts J. C. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. DICP. 1991 May;25(5):525–531. doi: 10.1177/106002809102500513. [DOI] [PubMed] [Google Scholar]
  5. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989 May 12;119(2):203–210. doi: 10.1016/0022-1759(89)90397-9. [DOI] [PubMed] [Google Scholar]
  6. Heifets L. B., Iseman M. D., Lindholm-Levy P. J. Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1986 Dec;30(6):927–932. doi: 10.1128/aac.30.6.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Heifets L. B., Iseman M. D., Lindholm-Levy P. J., Kanes W. Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother. 1985 Oct;28(4):570–575. doi: 10.1128/aac.28.4.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heifets L. Qualitative and quantitative drug-susceptibility tests in mycobacteriology. Am Rev Respir Dis. 1988 May;137(5):1217–1222. doi: 10.1164/ajrccm/137.5.1217. [DOI] [PubMed] [Google Scholar]
  9. Hoy J., Mijch A., Sandland M., Grayson L., Lucas R., Dwyer B. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis. 1990 Apr;161(4):801–805. doi: 10.1093/infdis/161.4.801. [DOI] [PubMed] [Google Scholar]
  10. Kondo E., Katayama T., Kawamura Y., Yasuda Y., Matsumoto K., Ishii K., Tanimoto T., Hinoo H., Kato T., Kyotani H. Isolation and characterization of new antibiotics resorcinomycins A and B. J Antibiot (Tokyo) 1989 Jan;42(1):1–6. doi: 10.7164/antibiotics.42.1. [DOI] [PubMed] [Google Scholar]
  11. Mehta R. T., Keyhani A., McQueen T. J., Rosenbaum B., Rolston K. V., Tarrand J. J. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob Agents Chemother. 1993 Dec;37(12):2584–2587. doi: 10.1128/aac.37.12.2584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peck R. A one-plate assay for macrophage bactericidal activity. J Immunol Methods. 1985 Sep 3;82(1):131–140. doi: 10.1016/0022-1759(85)90232-7. [DOI] [PubMed] [Google Scholar]
  13. Rolston K. V., Ho D. H., LeBlanc B., Bodey G. P. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients. Chemotherapy. 1990;36(5):365–372. doi: 10.1159/000238789. [DOI] [PubMed] [Google Scholar]
  14. Thom S. M., Horobin R. W., Seidler E., Barer M. R. Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J Appl Bacteriol. 1993 Apr;74(4):433–443. doi: 10.1111/j.1365-2672.1993.tb05151.x. [DOI] [PubMed] [Google Scholar]
  15. Wallace J. M., Hannah J. B. Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study. Chest. 1988 May;93(5):926–932. doi: 10.1378/chest.93.5.926. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES